植恩生物

Zhien Biopharma is a prominent integrated pharmaceutical company based in Chongqing, China, specializing in the research, development, and large-scale manufacturing of chemical drugs. The company is globally recognized as a leading producer of Orlistat, a key medication for weight management, and maintains a significant share of the domestic obesity treatment market. Beyond its proprietary product line, Zhien Biopharma operates as a comprehensive CDMO, providing end-to-end services from drug discovery to commercial production for global partners. Its therapeutic portfolio covers metabolic diseases, cardiovascular health, and anti-infectives, supported by multiple GMP-certified manufacturing facilities. The company is a central figure in the Chongqing pharmaceutical industry cluster and continues to expand its presence in international markets through high-quality API and finished dosage form exports.